RecruitingPhase 2Phase 3ACTRN12610000322033

The role of vitamin D in the treatment of nerve pain in diabetes

Vitamin D as an analgesic for neuropathic pain in type 2 diabetes


Sponsor

St Vincent's Hospital

Enrollment

60 participants

Start Date

Apr 1, 2010

Study Type

Interventional

Conditions

Summary

Vitamin D deficiency is common amongst people with type 2 diabetes. People with type 2 diabetes frequently develop painful neuropathy ("nerve pain" especially in the feet). The study hypothesis is that vitamin D supplementation may improve symptoms of nerve pain. The study is therefore designed to investigate the impact of vitamin D supplementation on nerve pain in people with type 2 diabetes


Eligibility

Sex: Both males and femalesMin Age: 40 YearssMax Age: 80 Yearss

Plain Language Summary

Simplified for easier understanding

This study is testing whether taking vitamin D supplements can reduce nerve pain in the feet in people with type 2 diabetes. Many people with type 2 diabetes develop a condition called diabetic neuropathy, which causes burning, tingling, or stabbing pain — usually in the feet. Vitamin D deficiency is common in people with diabetes, and researchers believe correcting this deficiency may help ease nerve pain. You may be eligible if: - You are between 40 and 80 years old - You have type 2 diabetes - You have painful nerve symptoms (especially in the feet) - Your vitamin D level is low (below 50 nmol/L) You may NOT be eligible if: - You have type 1 diabetes or another cause of diabetes - You have high calcium levels in your blood (hypercalcaemia) - You have a history of kidney stones Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Intramuscular vitamin D injection (300,000 units) at baseline

Intramuscular vitamin D injection (300,000 units) at baseline


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000322033